Raymond James & Associates Cellebrite Di Ltd. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Raymond James & Associates holds 27,630 shares of CLBT stock, worth $681,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,630Holding current value
$681,632% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLBT
# of Institutions
180Shares Held
107MCall Options Held
741KPut Options Held
205K-
Igp Investments (G.P.L.P), LP Herzliya, L321.1MShares$520 Million95.53% of portfolio
-
True Wind Capital Management, L.P.11.7MShares$289 Million81.05% of portfolio
-
Morgan Stanley New York, NY5.38MShares$133 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA4.39MShares$108 Million0.23% of portfolio
-
Nine Ten Capital Management LLC Evanston, IL4.33MShares$107 Million22.02% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $4.68B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...